Fact CheckerSign in

NCT07349004Recruiting

Neurogenetic And Hemodynamic Of Migraine Aura And Pfo

Association Between PFO and Migraine With Aura: A Case-Control Observational Study With Genetic and Neurosonological Analysis

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

The PFOCUS Study aims to clarify the relationship between patent foramen ovale (PFO) and migraine with aura (MA). Patients diagnosed with MA according to ICHD-3 criteria will be classified as cases (PFO+) or controls (PFO-) based on the presence or absence of a right-to-left shunt detected by transcranial Doppler or a previously documented PFO. The study will enroll 240 adult participants over 36 months. The primary objective is to determine whether genetic variants differ significantly between patients with MA with and without PFO. Secondary objectives include assessing cerebral blood flow regulation and platelet function in patients with MA with and without PFO. Participants will undergo a single study visit including the collection of demographic and clinical data and a comprehensive neurosonological assessment. This will include microembolic signal counts, cerebrovascular reactivity testing, and a contrast-enhanced transcranial Doppler study for shunt detection. Blood samples will be collected for whole-exome sequencing (with a focus on NOTCH3 and an expanded gene panel) and for platelet aggregometry. The study is expected to provide new insights into the biological mechanisms linking PFO and MA-potentially involving endothelial dysfunction, altered vascular smooth muscle responses, or platelet activation-thereby informing prevention strategies and guiding future research.

Status (registry)
Recruiting
Study type
Observational
Enrollment
240 (estimated)
First submitted
9 Jan 2026
Start date
24 Nov 2025
Primary completion date
24 Nov 2025
Lead sponsor
Azienda Usl di Bologna
Diseases
Migraine
NCT number
NCT07349004

What you commit to

  • Study type: Observational
  • Planned participants: 240
  • From 24 Nov 2025 to the primary completion date, 24 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of congenital heart disease

Who the study is looking for

  • Diagnosis of migraine with aura (according to Chapter 1.2 of the International Classification of Headache Disorders, 3rd edition \[ICHD-3\])
  • Age ≥ 18 years
  • Both sexes
  • Obtained written informed consent to participate in the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna
Coordinator of this site? Confirm its status
BolognaItalyRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.